MSB 2.91% $1.06 mesoblast limited

Ann: COVID ARDS Trial Topline 60-Day Results, page-1506

  1. 2,273 Posts.
    lightbulb Created with Sketch. 372
    Hi @stanjupiter my post wasnt in response to your excellent post it was at @RickyH who was trying to draw the bow (quoteing your post) that we don't need Reme for GVHD in children because they are getting Jakafi "off label" for which he has no evidence. Shade throwing on a day when the SP is being belted down on no news...

    cheers

    Prae
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.